Literature DB >> 9460066

Health expectancy and the problem of substitute morbidity.

H P Van de Water1.   

Abstract

During the past century, the developed world has not only witnessed a dramatic increase in life expectancy (ageing), but also a concomitant rise in chronic disease and disability. Consequently, the tension between 'living longer' on the one hand and health-related 'quality of life' on the other has become an increasingly important health policy problem. The paper deals with two consequences of this so-called epidemiological transition in population health. The first one concerns the question of how--given the impressive changes--population health can be measured in an adequate and policy relevant present-day fashion. The second one is the so-called phenomenon of 'substitute morbidity and mortality': more and more acute fatal diseases are replaced by non-fatal delayed degenerative diseases like dementia and arthritis. How the phenomenon of substitute morbidity and mortality affects the development of population health is illustrated with the epidemiological transitions, worldwide shifts in the main causes of death, assumptions used in models, adverse consequences of medical technologies and some results from intervention trials. Substitute morbidity and mortality may thwart our disease-specific expectations of interventions and asks for a shift to a 'total population health' perspective when judging potential health gains of interventions. Better understanding of the dynamics that underly the changes in population health is necessary. Implications for data collections are more emphasis on morbidity data and their relation with mortality, more longitudinal studies, stricter requirements for intervention trials and more use of modelling as a tool. A final recommendation is the promotion of integrative measures of population health. For the latter several results are presented suggesting that, although the amount of morbidity and disability is growing with an increasing life expectancy, this is mild unhealthiness in particular. This finding supports the 'dynamic equilibrium' theory. In absolute numbers, however, the burden of disease will continue to increase with further ageing of the population.

Entities:  

Mesh:

Year:  1997        PMID: 9460066      PMCID: PMC1692121          DOI: 10.1098/rstb.1997.0167

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  27 in total

1.  Ovarian hyperstimulation syndrome. A case history and review.

Authors:  T R Varma; R H Patel
Journal:  Acta Obstet Gynecol Scand       Date:  1988       Impact factor: 3.636

2.  A multistate analysis of active life expectancy.

Authors:  A Rogers; R G Rogers; L G Branch
Journal:  Public Health Rep       Date:  1989 May-Jun       Impact factor: 2.792

3.  Practice management for ovulation induction.

Authors:  L M Bonaventura
Journal:  J Reprod Med       Date:  1989-01       Impact factor: 0.142

Review 4.  The compression of morbidity: near or far?

Authors:  J F Fries
Journal:  Milbank Q       Date:  1989       Impact factor: 4.911

5.  The fourth stage of the epidemiologic transition: the age of delayed degenerative diseases.

Authors:  S J Olshansky; A B Ault
Journal:  Milbank Q       Date:  1986       Impact factor: 4.911

6.  Changing concepts of morbidity and mortality in the elderly population.

Authors:  K G Manton
Journal:  Milbank Mem Fund Q Health Soc       Date:  1982

7.  Aging, natural death, and the compression of morbidity.

Authors:  J F Fries
Journal:  N Engl J Med       Date:  1980-07-17       Impact factor: 91.245

8.  Birth weight less than 800 grams: changing outcomes and influences of gender and gestation number.

Authors:  E L Hoffman; F C Bennett
Journal:  Pediatrics       Date:  1990-07       Impact factor: 7.124

9.  The expectation of life without disability in England and Wales.

Authors:  A C Bebbington
Journal:  Soc Sci Med       Date:  1988       Impact factor: 4.634

10.  Active life expectancy.

Authors:  S Katz; L G Branch; M H Branson; J A Papsidero; J C Beck; D S Greer
Journal:  N Engl J Med       Date:  1983-11-17       Impact factor: 91.245

View more
  1 in total

1.  Taking multi-morbidity into account when attributing DALYs to risk factors: comparing dynamic modeling with the GBD2010 calculation method.

Authors:  Hendriek C Boshuizen; Wilma J Nusselder; Marjanne H D Plasmans; Henk H Hilderink; Bianca E P Snijders; René Poos; Coen H van Gool
Journal:  BMC Public Health       Date:  2017-02-14       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.